Genesco (GCO) Q3 2025 earnings summary

Executive summary

• Q3 FY25 net sales rose 3% year-over-year to $596.3 million, with comparable sales up 6% and e-commerce up 15%; Journeys segment comps surged 11%.

• Adjusted EPS was $0.61, surpassing guidance, while GAAP EPS was $(1.76) due to a $26.3 million U.S. deferred tax asset valuation allowance.

• Digital penetration reached 24% of retail sales, and inventory levels are well-positioned for the holiday season.

• Strategic initiatives at Journeys, including product assortment improvements and store resets, drove double-digit comp growth and offset declines at Schuh and Johnston & Murphy.

• Cost reduction and store optimization efforts contributed to profitability, with ongoing store closures and a robust start to Q4.

Financial highlights

• Q3 FY25 net sales were $596.3 million, up 2.9% year-over-year; comparable sales increased 6%, and e-commerce comps rose 15%.

• Gross margin was 47.8% (down 30 bps YoY); adjusted operating income was $10.3 million (1.7% of sales).

• Q3 net loss was $18.9 million, mainly due to the tax valuation allowance; adjusted Q3 earnings from continuing operations were $6.6 million ($0.61/share).

• Selling and administrative expenses were 46.1% of sales, improved by 10 bps YoY.

• Cash at quarter-end was $33.6 million; total debt $100.1 million, both improved YoY.

Outlook and guidance

• FY25 sales guidance raised to down 1% to flat vs. FY24, or flat to up 1% excluding the 53rd week; adjusted diluted EPS guidance increased to $0.80–$1.00.

• Journeys expected to see low-single digit sales growth; Schuh and Johnston & Murphy to decline.

• Capital expenditures for FY25 projected at $45–$50 million, focused on new stores, remodels, and omni-channel enhancements.

• Guidance assumes no further share repurchases and average shares outstanding of 11 million.

• Management expects sufficient liquidity for FY2025 and the foreseeable future, supported by cash, operations, and credit facilities.